Changing the Trajectory of Heart Failure and Kidney Disease

Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 Inhibitor

“…These findings are worthy of further inquiry, including studies to determine if SGLT2 inhibitors can be safely used to prevent AKI during acute illness of various types or with high-risk procedures, such as cardiac surgery or intravascular administration of iodinated contrast. Hospitalization might also represent a golden moment for implementation of an SGLT2 inhibitor in appropriate patients, especially those with CKD or heart failure (10). This could be a key strategy to improve the dismally low implementation rates of SGLT2 inhibitors for kidney and heart protection in suitable patients.…”